[1] Wang WZ, Baynosa RC, Zamboni WA. Therapeutic interventions against reperfusion injury in skeletal muscle. J Surg Res. 2011;171(1):175-182.
[2] Zhao ZQ, Corvera JS, Halkos ME, et al. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning. Am J Physiol Heart Circ Physiol. 2003;285(2):H579-588.
[3] McAllister SE, Ashrafpour H, Cahoon N, et al. Postconditioning for salvage of ischemic skeletal muscle from reperfusion injury: efficacy and mechanism. Am J Physiol Regul Integr Comp Physiol. 2008;295(2):R681-689.
[4] Yan H, Zhang F, Kochevar AJ, et al. The effect of postconditioning on the muscle flap survival after ischemia-reperfusion injury in rats. J Invest Surg. 2010;23(5):249-256.
[5] Park JW, Kang JW, Jeon WJ, et al. Postconditioning protects skeletal muscle from ischemia-reperfusion injury. Microsurgery. 2010;30(3):223-229.
[6] Guo XS, Li YZ, Liu XH, et al. Calcineurin mediates the protective effect of postconditioning on skeletal muscle. Shock. 2011;36(3):312-316.
[7] Lee JI, Wook Nha K, Suh JS, et al. Remote postconditioning attenuates ischemia/reperfusion injury in rat skeletal muscle through mitochondrial ATP-sensitive K+ channel-dependent mechanism. J Reconstr Microsurg. 2013;29(9):571-578.
[8] 彭龙龙,阳富春,薄占东,等.不同缺血后调适方案对大鼠模型肢体骨骼肌缺血再灌注损伤的影响[J].中国组织工程研究,2015,19(5):739-744.
[9] Hausenloy DJ, Yellon DM. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway. Cardiovasc Res. 2004;61(3): 448-460.
[10] Hausenloy DJ, Yellon DM. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection. Heart Fail Rev. 2007;12(3-4):217-234.
[11] Heusch G. Treatment of Myocardial Ischemia/Reperfusion Injury by Ischemic and Pharmacological Postconditioning. Compr Physiol. 2015;5(3):1123-1145.
[12] Lamas S, Marsden PA, Li GK, et al. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc Natl Acad Sci U S A. 1992;89(14):6348-6352.
[13] Fleming I, Busse R. Molecular mechanisms involved in the regulation of the endothelial nitric oxide synthase. Am J Physiol Regul Integr Comp Physiol. 2003;284(1): R1-12.
[14] Chen CA, Wang TY, Varadharaj S, et al. S-glutathionylation uncouples eNOS and regulates its cellular and vascular function. Nature. 2010;468(7327): 1115-1118.
[15] Chen CA, Druhan LJ, Varadharaj S, et al. Phosphorylation of endothelial nitric-oxide synthase regulates superoxide generation from the enzyme. J Biol Chem. 2008;283(40):27038-27047.
[16] Ozturk K, Ozyurt H, Somay A, et al. The effects of nitric oxide donor molsidomine on skeletal muscle damage in a rat hind limb model of ischemia-reperfusion. Eur Surg Res. 2009;42(2):71-77.
[17] Roberts BW, Mitchell J, Kilgannon JH, et al. Nitric oxide donor agents for the treatment of ischemia/reperfusion injury in human subjects: a systematic review. Shock. 2013;39(3):229-239.
[18] Talukder MA, Yang F, Shimokawa H, et al. eNOS is required for acute in vivo ischemic preconditioning of the heart: effects of ischemic duration and sex. Am J Physiol Heart Circ Physiol. 2010;299(2):H437-445.
[19] Hausenloy DJ, Yellon DM. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion. J Mol Cell Cardiol. 2003;35(4):339-341.
[20] 贺永贵,李王芳,伊红丽,等.黄芪甲苷抑制GSK-3β活性介导大鼠心肌缺血/再灌注损伤作用的线粒体机制研究[J].中国药理学通报,2014,30(3):402-406.
[21] Miyauchi T, Miyata M, Ikeda Y, et al. Waon therapy upregulates Hsp90 and leads to angiogenesis through the Akt-endothelial nitric oxide synthase pathway in mouse hindlimb ischemia. Circ J. 2012;76(7): 1712-1721.
[22] Hernández-Reséndiz S, Palma-Flores C, De Los Santos S, et al. Reduction of no-reflow and reperfusion injury with the synthetic 17β-aminoestrogen compound Prolame is associated with PI3K/Akt/eNOS signaling cascade. Basic Res Cardiol. 2015;110(2):1.
[23] Ming XF, Viswambharan H, Barandier C, et al. Rho GTPase/Rho kinase negatively regulates endothelial nitric oxide synthase phosphorylation through the inhibition of protein kinase B/Akt in human endothelial cells. Mol Cell Biol. 2002;22(24):8467-8477.
[24] Wolfrum S, Dendorfer A, Rikitake Y, et al. Inhibition of Rho-kinase leads to rapid activation of phosphatidylinositol 3-kinase/protein kinase Akt and cardiovascular protection. Arterioscler Thromb Vasc Biol. 2004;24(10):1842-1847.
[25] Fleming I, Fisslthaler B, Dimmeler S, et al. Phosphorylation of Thr(495) regulates Ca(2+)/ calmodulin-dependent endothelial nitric oxide synthase activity. Circ Res. 2001;88(11):E68-75.
[26] Goligorsky MS, Li H, Brodsky S, et al. Relationships between caveolae and eNOS: everything in proximity and the proximity of everything. Am J Physiol Renal Physiol. 2002;283(1):F1-10.
[27] Sugimoto M, Nakayama M, Goto TM, et al. Rho-kinase phosphorylates eNOS at threonine 495 in endothelial cells. Biochem Biophys Res Commun. 2007;361(2): 462-467.
[28] Michell BJ, Chen Zp, Tiganis T, et al. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem. 2001; 276(21):17625-17628.
[29] Javadov S, Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection. Cell Physiol Biochem. 2007;20(1-4):1-22.
[30] Shahzad T, Kasseckert SA, Iraqi W, et al. Mechanisms involved in postconditioning protection of cardiomyocytes against acute reperfusion injury. J Mol Cell Cardiol. 2013;58:209-216.
[31] Juhaszova M, Zorov DB, Kim SH, et al. Glycogen synthase kinase-3beta mediates convergence of protection signaling to inhibit the mitochondrial permeability transition pore. J Clin Invest. 2004;113(11): 1535-1549.
[32] Bopassa JC, Ferrera R, Gateau-Roesch O, et al. PI 3-kinase regulates the mitochondrial transition pore in controlled reperfusion and postconditioning. Cardiovasc Res. 2006;69(1):178-185.
[33] Cohen MV, Yang XM, Downey JM. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation. 2007;115(14):1895-1903. |